Trial Results Support Transition into Late-Stage Development with Program Expected to be Phase 2b/3-ready in H2 2026 BERLIN, GERMANY, January 29, 2026 – OMEICOS, a clinical-stage biopharmaceutical ...

EMA committee recommends marketing approval for UCB’s Kygevvi to treat thymidine kinase 2 deficiency: Brussels, Belgium Monday, February 2, 2026, 15:00 Hrs [IST] UCB, a global b ...

How One Tiny Cellular Structure Holds the Key to Better Health & Longevity — and How You Can Harness It ...

The structural and functional characteristics of mitochondria shape their role as signaling organelles, with far-reaching ...

Micro- and nanoplastics are increasingly detected in human tissues, including the brain, and experimental evidence suggests ...

Trial Results Support Transition into Late-Stage Development with Program Expected to be Phase 2b/3-ready in H2 2026 ...

Bipolar disorder (BD) is a major mental disorder, affecting 1% of the global population. Patients suffering from BD ...

An investigation by researchers from Case Western Reserve University School of Medicine in the US has filled in a missing link between the toxic build-up of proteins in the neurodegenerative condition ...

X Health System, a precision wellness company focused on data-driven human optimization, today announced the addition of 10X MitoScreen (TM), an advanced mitochondrial health assessment, through a ...

New research by UCLA Health and UC San Francisco has uncovered why certain brain cells are more resilient than others to the buildup of a toxic protein that is a hallmark of Alzheimer's disease and ...

X Health System, a precision wellness company focused on data-driven human optimization, today announced the addition of 10X MitoScreen™, an advanced mitochondrial health assessment, through a ...

Population aging is reshaping the landscape of respiratory disease, with COPD, idiopathic pulmonary fibrosis, bronchiectasis, ...